MISSISSAUGA, ON – Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that VABYSMO® (faricimab injection) is now publicly funded for macular edema secondary to retinal vein occlusion (RVO) on… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria“), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization (“CRO“) has completed… Read More
CHICAGO, ILL – DHR Global, a leading global executive search and talent advisory firm, announced the appointment of Priya Taneja as Chief Executive Officer, effective September 1, 2025. Taneja will succeed Geoff Hoffmann,… Read More
VANCOUVER, BC – Sonic Incytes Medical Corp, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Velacur ONE™, its point-of-care ultrasound elastography device. Building… Read More
KT-3283, a duel PARP-HDAC inhibitor, to serve as first development program in NanoPalm’s strategic expansion into the oncology field VANCOUVER, BC & RIYADH, SA – Rakovina Therapeutics Inc. (“Rakovina” or… Read More
